tiprankstipranks
Universe Pharmaceuticals (UPC)
NASDAQ:UPC
US Market
Holding UPC?
Track your performance easily

Universe Pharmaceuticals (UPC) Income Statement

80 Followers

Universe Pharmaceuticals Income Statement

Last quarter (Q4 2023), Universe Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Universe Pharmaceuticals's net income was $―. See Universe Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
-$ 32.31M$ 40.14M$ 47.98M$ 30.70M$ 33.23M
Cost of Revenue
-$ 21.99M$ -18.25M$ 22.66M$ 16.61M$ 19.82M
Gross Profit
-$ 10.32M$ 21.89M$ 25.33M$ 14.09M$ 13.41M
Operating Expense
-$ 14.08M$ -29.33M$ 11.82M$ 3.74M$ 3.36M
Operating Income
-$ -3.76M$ -7.39M$ 13.51M$ 10.35M$ 10.05M
Net Non Operating Interest Income Expense
-$ -156.79K$ -162.40K$ -101.60K$ -123.76K$ -129.27K
Other Income Expense
-$ -69.60K$ 431.89K$ -270.38K$ -125.63K$ -268.47K
Pretax Income
-$ -3.85M$ -7.98M$ 13.68M$ 10.10M$ 9.65M
Tax Provision
-$ 2.31M$ 752.42K$ 2.36M$ 2.54M$ 2.10M
Earnings From Equity Interest Net Of Tax
-$ 31.07K$ 38.59K$ 30.83K--
Net Income Common Stockholders
-$ -6.16M$ -8.74M$ 11.32M$ 7.56M$ 7.55M
Basic EPS
-$ -1.70$ -0.40$ 0.60$ 0.36$ 0.36
Diluted EPS
-$ -1.70$ -0.40$ 0.60$ 0.36$ 0.36
Basic Average Shares
-$ 3.63M$ 21.75M$ 18.98M$ 21.00M$ 21.00M
Diluted Average Shares
-$ 3.63M$ 21.75M$ 18.98M$ 21.00M$ 21.00M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-$ 36.07M$ -47.58M$ 34.47M$ 20.35M$ 23.18M
Net Income From Continuing And Discontinued Operation
-$ -6.16M$ -8.74M$ 11.32M$ 7.56M$ 7.55M
Normalized Income
----$ 7.63M$ 7.78M
Interest Expense
----$ 123.76K$ 129.27K
EBIT
--$ -7.82M$ 13.78M$ 10.22M$ 9.78M
EBITDA
--$ -7.29M$ 14.23M$ 10.63M$ 10.20M
Currency in USD

Universe Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis